Qvanteq AG develops novel biofunctional surfaces to address and overcome the clinical adverse effects of today’s vascular stents.
Qvanteq AG develops novel biofunctional surfaces to address and overcome the clinical adverse effects of today’s vascular stents.
Technoparkstrasse 1, 8005 Zürich, Switzerland